Guidelines
HAP & VAP

HAP & VAP

Guideline Use

Dose recommendations are based on patients with normal renal function. Refer to dosing in renal impairment

These guidelines may not be appropriate for patients with a history of multi-drug resistant organisms. Consider infectious disease consultation

Diagnostics

  • Respiratory evidence
    • Increasing O2 requirements
    • Purulent sputum
  • Radiographic evidence of pneumonia
  • Signs/Symptoms of infection:
    • Leukocytosis/leukopenia
    • Hyper/hypothermia
  • Respiratory Culture

  • Blood Culture x 2

Microbiology

Treatment

Deescalation

Additional Information

These recommendations are meant to guide empiric therapeutic decision making and are not meant to replace sound clinical decision making. Definitive therapy should be based on culture and susceptibility reports

  • Kyle D. Massey, PharmD

  • Rebekah Gass, MD

  • Brian McCullough, PharmD

  • HAP/VAP Guidelines

  • CAP Guidelines